The Food and Drug Administration rejected a bid from Elon Musk's human brain chips startup Neuralink to start human trials, according to Reuters.
Share:
More In Science
Fauci Says Halt of Coronavirus Trial Is 'Safety Valve' at Work
Dr. Anthony Fauci says AstraZeneca's suspension of its COVID-19 vaccine study shows “one of the safety valves” built into the research to spot any potential problems.
'Mighty Mice' Stay Musclebound in Space, Boon for Astronauts
Scientists who sent bulked-up, mutant “mighty mice” to the International Space Station say the animals held onto their muscle during the monthlong flight.
Companies Testing Vaccines Pledge Safety, High Standards
Top executives of nine drugmakers likely to produce the first vaccines against the new coronavirus are taking the extraordinary step of promising they'll be safe and effective.
Cosmic Legos: Black Holes Merge Into Never Before Seen Size
Astrophysicists detected the signal from a long ago violent collision of two black holes that created a new one of a size that had never been seen before.
CDC Tells States: Be Ready to Distribute Vaccines on Nov. 1
The timeline raised concern among public health experts about an “October surprise" — a vaccine approval driven by political considerations ahead of a presidential election, rather than science.
Thailand Hits 100 Days With no Local Coronavirus Transmissions
Thailand’s prime minister is congratulating the nation for having achieved 100 days without a confirmed locally transmitted case of the coronavirus.
Third Coronavirus Vaccine Reaches Major Hurdle: Final U.S. Testing
A third leading candidate COVID-19 vaccine has entered a final stage of human testing in the United States.
NYC Delays Start of School Year to Allow More Prep Time
Mayor Bill de Blasio says New York City is delaying sending students back to classrooms in the nation’s largest public school system.
West Virginia University Uses Tech to Track and Predict Coronavirus Outbreaks
West Virginia University has developed technology that can predict coronavirus outbreaks with 90 percent accuracy. Dr. Ali Rezai, executive chair of WVU's Rockefeller Neuroscience Institute, joined Cheddar to discuss the technology and protocols the university will implement to mitigate the spread of COVID-19.
